Latest Placebos news
Open-Label Placebo Plus Treatment Rationale Effective for PMS
posted March 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Open-Label Placebo May Reduce Fatigue in Cancer Survivors
posted February 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Open-label placebo may reduce fatigue in cancer survivors, according to a study published online Feb. 9 in Scientific Reports.
Open-Label Placebo Treatments Can Ease Chronic Low Back Pain
posted October 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients who knowingly took a placebo pill while undergoing traditional treatment for lower back pain had less pain and disability than those who received traditional treatment alone, according to a study published online Oct. 13 in Pain.
Branded Rx May Up the Power of Placebo
posted November 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
A brand-name label made a placebo tablet work as well as an active nonsteroidal anti-inflammatory drug, according to research published online Oct. 12 in Health Psychology.
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Study IDs Neurobiological Roots of Sensory Over-Responsivity Monthly Specialist Briefings
Stay Connected
